Circulogene Expands Liquid Biopsy Testing Capabilities, Adds Three cfRNA-based NSCLC Tests Supporting Personalized Treatment for Lung Cancer Patients

Circulogene Expands Liquid Biopsy Testing Capabilities, Adds Three cfRNA-based NSCLC Tests Supporting Personalized Treatment for Lung Cancer Patients Droplet-volume, single-tube testing capabilities include both cfDNA- and cfRNA-based tests using NGS and real-time PCR platforms for … Continue reading Circulogene Expands Liquid Biopsy Testing Capabilities, Adds Three cfRNA-based NSCLC Tests Supporting Personalized Treatment for Lung Cancer Patients